Stock index futures fell on Tuesday, as President Donald Trump fired Federal Reserve Governor Lisa Cook on Monday amid ...

Lilly announces positive trial results for its pill form GLP-1 medication, paving the way for global regulatory approval this ...

The results of the ATTAIN-2 study, which involved people with obesity or overweight and type 2 diabetes, showed that the oral ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Eli Lilly said Tuesday it will soon ask global regulators to approve its weight-loss pill following a third successful Phase 3 study.

AbbVie agreed to pay up to $1.2 billion to buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major ...

Dementia costs, including direct, indirect, and tangible costs, in the United States will total $781 billion in 2025, ...